These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27393547)

  • 1. Comparison of TaqMan(®) Array Card and MYCOTB(TM) with conventional phenotypic susceptibility testing in MDR-TB.
    Foongladda S; Banu S; Pholwat S; Gratz J; O-Thong S; Nakkerd N; Chinli R; Ferdous SS; Rahman SM; Rahman A; Ahmed S; Heysell S; Sariko M; Kibiki G; Houpt E
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1105-12. PubMed ID: 27393547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing.
    Ssengooba W; Nakayita G; Namaganda CC; Joloba ML
    PLoS One; 2018; 13(6):e0199638. PubMed ID: 29953491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
    Ceyhan İ; Vezir S
    Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of two methods for the detection of antituberculous drug susceptibility in Mycobacterium tuberculosis complex isolates: sensititre MycoTB MIC plate and the indirect agar proportion methods].
    Varıcı Balcı FK; Çavuşoğlu C
    Mikrobiyol Bul; 2018 Apr; 52(2):123-134. PubMed ID: 29933730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
    Mpagama SG; Houpt ER; Stroup S; Kumburu H; Gratz J; Kibiki GS; Heysell SK
    BMC Infect Dis; 2013 Sep; 13():432. PubMed ID: 24034230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
    Xia H; Zheng Y; Zhao B; van den Hof S; Cobelens F; Zhao Y
    PLoS One; 2017; 12(1):e0169413. PubMed ID: 28081169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Park J; Shin SY; Kim K; Park K; Shin S; Ihm C
    Ann Lab Med; 2018 Jul; 38(4):316-323. PubMed ID: 29611381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testing.
    Chakravorty S; Lee JS; Cho EJ; Roh SS; Smith LE; Lee J; Kim CT; Via LE; Cho SN; Barry CE; Alland D
    J Clin Microbiol; 2015 Jan; 53(1):43-51. PubMed ID: 25339395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
    Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
    Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
    PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country.
    Ahmad S; Mokaddas E; Al-Mutairi N; Eldeen HS; Mohammadi S
    PLoS One; 2016; 11(4):e0153563. PubMed ID: 27096759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
    Yu X; Ma YF; Jiang GL; Chen ST; Wang GR; Huang HR
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):329-34. PubMed ID: 27046713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of the Sensititre MycoTB Plate, the Bactec MGIT 960, and a Microarray-Based Molecular Assay for the Detection of Drug Resistance in Clinical Mycobacterium tuberculosis Isolates in Moscow, Russia.
    Nosova EY; Zimenkov DV; Khakhalina AA; Isakova AI; Krylova LY; Makarova MV; Galkina KY; Krasnova MA; Safonova SG; Litvinov VI; Gryadunov DA; Bogorodskaya EM
    PLoS One; 2016; 11(11):e0167093. PubMed ID: 27902737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs.
    Lee J; Armstrong DT; Ssengooba W; Park JA; Yu Y; Mumbowa F; Namaganda C; Mboowa G; Nakayita G; Armakovitch S; Chien G; Cho SN; Via LE; Barry CE; Ellner JJ; Alland D; Dorman SE; Joloba ML
    Antimicrob Agents Chemother; 2014; 58(1):11-8. PubMed ID: 24100497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
    Rahman SMM; Nasrin R; Rahman A; Ahmed S; Khatun R; Uddin MKM; Rahman MM; Banu S
    PLoS One; 2021; 16(12):e0261329. PubMed ID: 34914803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
    Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.